Jeffrey M. Jonas founded AVAX Technologies, Inc. and Evogen, Inc. Presently, he is President, Chief Executive Officer & Director at SAGE Therapeutics, Inc.
He is also on the board of Pharmaceutical Research & Manufacturers of America, Karuna Therapeutics, Inc., Decibel Therapeutics, Inc. and Generation Bio Co.
In his past career he occupied the position of Chairman, President & Chief Executive Officer of Evogen, Inc., President, Chief Executive Officer & Director at AVAX Technologies, Inc., Vice President-Research & Clinical Development at Upjohn Laboratories LLC, Executive Vice President of Ionis Pharmaceuticals, Inc., President of Shire Regenerative Medicine, Inc., Chief Medical Officer & Executive Vice President at Forest Laboratories, Inc., President-Regenerative Medicine Division at Shire Plc, Chief Resident at McLean Hospital, Inc. and Chief Resident at Harvard Medical School.
Dr. Jonas received an undergraduate degree from Amherst College and a doctorate from Harvard Medical School.